Literature DB >> 12424329

Effects of lycopene supplementation in patients with localized prostate cancer.

Omer Kucuk1, Fazlul H Sarkar, Zora Djuric, Wael Sakr, Michael N Pollak, Fred Khachik, Mousumi Banerjee, John S Bertram, David P Wood.   

Abstract

Epidemiological studies have shown an inverse association between dietary intake of lycopene and prostate cancer risk. We conducted a clinical trial to investigate the biological and clinical effects of lycopene supplementation in patients with localized prostate cancer. Twenty-six men with newly diagnosed prostate cancer were randomly assigned to receive a tomato oleoresin extract containing 30 mg of lycopene (n = 15) or no supplementation (n = 11) for 3 weeks before radical prostatectomy. Biomarkers of cell proliferation and apoptosis were assessed by Western blot analysis in benign and cancerous prostate tissues. Oxidative stress was assessed by measuring the peripheral blood lymphocyte DNA oxidation product 5-hydroxymethyl-deoxyuridine (5-OH-mdU). Usual dietary intake of nutrients was assessed by a food frequency questionnaire at baseline. Prostatectomy specimens were evaluated for pathologic stage, Gleason score, volume of cancer, and extent of high-grade prostatic intraepithelial neoplasia. Plasma levels of lycopene, insulin-like growth factor-1, insulin-like growth factor binding protein-3, and prostate-specific antigen were measured at baseline and after 3 weeks of supplementation or observation. After intervention, subjects in the intervention group had smaller tumors (80% vs 45%, less than 4 ml), less involvement of surgical margins and/or extra-prostatic tissues with cancer (73% vs 18%, organ-confined disease), and less diffuse involvement of the prostate by high-grade prostatic intraepithelial neoplasia (33% vs 0%, focal involvement) compared with subjects in the control group. Mean plasma prostate-specific antigen levels were lower in the intervention group compared with the control group. This pilot study suggests that lycopene may have beneficial effects in prostate cancer. Larger clinical trials are warranted to investigate the potential preventive and/or therapeutic role of lycopene in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424329     DOI: 10.1177/153537020222701007

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  35 in total

1.  Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Authors:  Iftekhar U Ahmad; Jeffrey D Forman; Fazlul H Sarkar; Gilda G Hillman; Elisabeth Heath; Ulka Vaishampayan; Michael L Cher; Fundagul Andic; Peter J Rossi; Omer Kucuk
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

3.  Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.

Authors:  Ramachandran Venkitaraman; Karen Thomas; Phillip Grace; David P Dearnaley; Alan Horwich; Robert A Huddart; Christopher C Parker
Journal:  Tumour Biol       Date:  2010-02-16

Review 4.  Novel targets for prostate cancer chemoprevention.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 5.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

6.  Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.

Authors:  Hind A Beydoun; Monal R Shroff; Ravinder Mohan; May A Beydoun
Journal:  Cancer Causes Control       Date:  2011-07-29       Impact factor: 2.506

Review 7.  Dietary antioxidants and prostate cancer: a review.

Authors:  Terrence M Vance; Joseph Su; Elizabeth T H Fontham; Sung I Koo; Ock K Chun
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

8.  Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway.

Authors:  Chongshan Dai; Shusheng Tang; Sijun Deng; Shen Zhang; Yan Zhou; Tony Velkov; Jian Li; Xilong Xiao
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 9.  Cellular signaling perturbation by natural products.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Cell Signal       Date:  2009-03-16       Impact factor: 4.315

Review 10.  Are the health attributes of lycopene related to its antioxidant function?

Authors:  John W Erdman; Nikki A Ford; Brian L Lindshield
Journal:  Arch Biochem Biophys       Date:  2008-11-01       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.